Manager-track GQP quality assurance for Nippon Kayaku's pharmaceuticals: data review for manufacturing sites in Japan and overseas, audits, regulatory filings and developing junior staff.
Nippon Kayaku, based in Marunouchi, Tokyo, runs three business units. Mobility & Imaging applies explosives technology to airbag inflators, micro gas generators for seat-belt pretensioners and squib igniters, and its Polatechno business makes polarizers for LCDs and projectors, retardation films and X-ray analyzer parts.
Fine Chemicals supplies epoxy resins for semiconductor encapsulation, UV-curable resins, dyes, and catalysts for producing acrylic and methacrylic acid. Life Science sells anticancer drugs, a line it began with BREO in 1969, and agrochemicals. The group had 5,946 employees at the end of March 2026.
- Salary range
- ¥5.2M – ¥11M
- Median
- ¥6.4M – ¥8.1M
- Most requested
- Japanese posting, level unstated 6
Measured from the 6 listings Ranked has live for Nippon Kayaku. Japanese level, visa signal and skills are AI-graded from each posting and can be wrong — confirm against the employer's original posting before applying.
6
open positions at Nippon Kayaku
Design injectable formulations for anticancer drugs and biosimilars, from formulation and process studies to scale-up, CTD preparation for approval filings and CMC development support.
Develop new dry film resists for MEMS and semiconductor packaging, from formulation design through pilot production and scale-up to commercialisation, working with customers.
Lead development of wet-process chemicals for semiconductors, such as resist strippers and dry-etch residue removers, from formulation design through scale-up and commercialization.
Research and develop materials for water-based industrial inkjet inks: core material development, ink formulation design, evaluation methods and new ink technology foundations.
Handle GQP quality assurance for Nippon Kayaku's pharmaceuticals: reviewing data from manufacturing sites in Japan and overseas, risk management, audits, and regulatory filings.